US Stock MarketDetailed Quotes

Genmab (GMAB)

Watchlist
  • 27.500
  • +0.280+1.03%
Close Apr 2 16:00 ET
  • 27.500
  • 0.0000.00%
Post 16:10 ET
17.67BMarket Cap17.89P/E (TTM)

Genmab (GMAB) Revenue Breakdown Overview

By Business/Source

Currency:USD
2025/FY
Stock NameRevenueRatio
DARZALEX2.44B65.67%
Kesimpta443M11.91%
Net product sales398M10.70%
Other111M2.98%
TEPEZZA105M2.82%
Milestone revenue97M2.61%
Collaboration revenue70M1.88%
Reimbursement revenue53M1.42%
View all

By Country/Region

Currency:USD
2025/FY
Stock NameRevenueRatio
Denmark3.33B89.41%
Japan213M5.73%
United States180M4.84%
Netherlands1M0.03%
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 4 local time, Trump issued a 48-hour ultimatum, demanding that Iran open the Strait of Hormuz by April 6 or face a 'catastrophe.' I Show More